No Detail Found!

Exosomes derived from chronic myeloid leukemia cells: roles in disease progression, survival, and treatment

Author(s)
SAYEH PARKHIDEH Shahid Beheshti University of Medical Sciences, Tehran, Iran
MAHSHID MEHDIZADEH Shahid Beheshti University of Medical Sciences, Tehran, Iran
ABBAS HAJIFATHALI Shahid Beheshti University of Medical Sciences, Tehran, Iran
HANIYEH GHAFFARI NAZARI Shahid Beheshti University of Medical Sciences, Tehran, Iran
ELHAM ROSHANDEL Shahid Beheshti University of Medical Sciences, Tehran, Iran
REZA MIRFAKHRAIE Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract
Exosomes, biologically active extracellular vesicles, are derived from normal and neoplastic cells. Emerging evidence revealed that exosomes modulate cell-cell communication and involve in hemostatic and pathologic processes. Recent studies have shown that exosomes released from cancer cells such as chronic myeloid leukemia cells could act as a key mediator in tumor induction and progression. Myeloid cells-derived exosomes affect different processes including angiogenesis, neoplastic proliferation, tumor cell survival, and imatinib resistance. These exosomes induce angiogenesis and tumor progression by IL-8 overexpression in both leukemic and bone marrow stromal cells. Exosomes cargo could alter the expression of different adhesion molecules, antiand pro-apoptotic molecules, cytokines, and chemokines such as VCAM-1, ICAM-1, BCL, BAD, BAX, TGF-ß, TNF-a, CXCL12 which affect tumor migration, homing, survival, and growth. CML-derived exosomes can also regulate signal transduction pathways, such as ERK/MAPK, ERK/Akt, EGFR/Ras, and Wnt. Furthermore, they can be applied as a vehicle for drug delivery or sensitization of drug-resistant cells. Here, we reviewed the role of chronic myeloid cell-derived exosomes in tumor growth, survival, and resistance to treatment.
Publication Details
Page(s) 1533-1539
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 15, Issue: 5, Year: 2021

Request the full text from PASTIC

Keywords
angiogenesis, Drug resistance., Tyrosine kinase inhibitor, Exosome, Chronic myeloid leukemia
0

Citations

0

Downloads

35

Views